Obinutuzumab Interactions
There are 178 drugs known to interact with obinutuzumab, along with 5 disease interactions. Of the total drug interactions, 50 are major, and 128 are moderate.
- View all 178 medications that may interact with obinutuzumab
- View obinutuzumab disease interactions (5)
Most frequently checked interactions
View interaction reports for obinutuzumab and the medicines listed below.
- Acidophilus (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Adderall XR (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Afrin Original (oxymetazoline nasal)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aleve (naproxen)
- Align (bifidobacterium infantis)
- Alka-Seltzer Plus Cold (acetaminophen / chlorpheniramine / phenylephrine)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- AquADEKs (multivitamin with minerals)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- Coenzyme Q10 (ubiquinone)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- Flagyl (metronidazole)
- Jardiance (empagliflozin)
- Lexapro (escitalopram)
- Metoprolol Succinate ER (metoprolol)
- Norco (acetaminophen / hydrocodone)
- Paracetamol (acetaminophen)
- Plaquenil (hydroxychloroquine)
- Qvar RediHaler (beclomethasone)
- Retinol (vitamin a topical)
- Solu-Medrol (methylprednisolone)
- Synthroid (levothyroxine)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Obinutuzumab disease interactions
There are 5 disease interactions with obinutuzumab which include:
- Anti-CD20 antibodies – hepatitis B
- Anti-CD20 antibodies – infections
- tumor lysis syndrome
- cardiopulmonary disease
- cytopenias
Report options
More about obinutuzumab
- obinutuzumab consumer information
- Compare alternatives
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Gazyva
Gazyva is used to treat chronic lymphocytic leukemia (CLL) or follicular lymphoma (FL) in adults ...
Treanda
Treanda (bendamustine) is used to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
